EDVA Earnings Endovia Health Sciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–14 of 14
| Q1 2026 | 2026-03-31 | -1.88 | 2026-05-20 | 10-Q |
| FY 2025 | 2025-12-31 | -47.88 | 2026-04-15 | 10-K |
| Q1 2025 | 2025-03-31 | -7.88 | — | — |
| FY 2024 | 2024-12-31 | -70.72 | — | — |
| Q3 2023 | 2023-09-30 | -20.80 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | -20.80 | 2023-08-14 | 10-Q |
| Q3 2022 | 2022-09-30 | -22.40 | — | — |
| Q2 2022 | 2022-06-30 | -25.60 | — | — |
| Q1 2022 | 2022-03-31 | -25.60 | 2022-05-16 | 10-Q |
| FY 2021 | 2021-12-31 | -163.20 | 2022-03-31 | 10-K |
| Q1 2021 | 2021-03-31 | -30.40 | — | — |
| FY 2020 | 2020-12-31 | -169.60 | — | — |
| FY 2019 | 2019-12-31 | -6.40 | 2020-03-27 | 10-K |
| FY 2018 | 2018-12-31 | 1.60 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.